Free Trial

Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume

→ Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad)
Free CRNX Stock Alerts
$46.86
-0.61 (-1.29%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends

Crinetics Pharmaceuticals Short Interest Data

Current Short Interest
4,910,000 shares
Previous Short Interest
4,910,000 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$247.91 million
Short Interest Ratio
5.5 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
78,860,000 shares
Percentage of Shares Shorted
6.23%
Today's Trading Volume
738,452 shares
Average Trading Volume
935,578 shares
Today's Volume Vs. Average
79%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Crinetics Pharmaceuticals ?

Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRNX Short Interest Over Time

CRNX Days to Cover Over Time

CRNX Percentage of Float Shorted Over Time

Crinetics Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49
4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82
4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68
3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81
3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93
2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94
2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92
1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48
1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19
12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58
12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46
11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79
11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88
10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29
10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11
9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74
9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49
8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32
8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72
7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00
7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37
6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02
6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77
5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83
5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33
4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54
4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93
3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06
3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19
2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64
2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97
1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61
1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04
12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30
12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24
11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87
11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24
10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46
10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66
9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64
Obama’s Forever Term [exposed] (Ad)

Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America.

Start streaming it now at no cost here
9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37
8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88
8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37
7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21
7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71
6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65
6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66
5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75
5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75
4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32
4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00
3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95
3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08
2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02
2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73
1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89
1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01
12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41
12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17
11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32
11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99
10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93
10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49
9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05
9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50
8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57
8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26
7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98
7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71
6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85
6/15/20211,330,000 shares $24.25 million -8.3%4.6%7.9 $18.23
5/28/20211,450,000 shares $25.45 million -4.6%5.0%10.2 $17.55
5/14/20211,520,000 shares $24.17 million -0.7%N/A12 $15.90
4/30/20211,530,000 shares $27.17 million -0.7%N/A11.1 $17.76
4/15/20211,540,000 shares $25.29 million +2.0%N/A11.1 $16.42
3/31/20211,510,000 shares $23.31 million -2.6%N/A11 $15.44
3/15/20211,550,000 shares $26.24 million +1.3%N/A11.1 $16.93
2/26/20211,530,000 shares $23.03 million +10.9%N/A11.2 $15.05
2/12/20211,380,000 shares $23.78 million -7.4%N/A9 $17.23
1/29/20211,490,000 shares $22.22 million +2.1%N/A9.5 $14.91
1/15/20211,460,000 shares $21.58 million +1.4%N/A8.3 $14.78
12/31/20201,440,000 shares $19.71 million +9.9%N/A8.2 $13.69
12/15/20201,310,000 shares $17.99 million +0.8%N/A8.1 $13.73
11/30/20201,300,000 shares $18.67 million +3.2%N/A8.8 $14.36
11/15/20201,260,000 shares $16.23 million +7.7%N/A9.1 $12.88
10/30/20201,170,000 shares $14.60 million -14.6%N/A9.9 $12.48
10/15/20201,370,000 shares $22.15 million -3.5%N/A13.2 $16.17
9/30/20201,420,000 shares $22.25 million +2.2%N/A14.3 $15.67
9/15/20201,390,000 shares $22.27 million -3.5%N/A8.7 $16.02
8/31/20201,440,000 shares $23.08 million -0.7%N/A7.6 $16.03
Obama’s Forever Term [exposed] (Ad)

Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America.

Start streaming it now at no cost here
8/14/20201,450,000 shares $22.05 million -2.7%N/A7.1 $15.21
7/31/20201,490,000 shares $20.68 million -15.8%N/A6.8 $13.88
7/15/20201,770,000 shares $26.92 million -30.3%N/A8.1 $15.21
6/30/20202,540,000 shares $45.42 million +84.1%10.6%10.4 $17.88
6/15/20201,380,000 shares $23.54 million No Change5.7%7.2 $17.06
5/29/20201,380,000 shares $22.55 million +3.0%5.8%8.7 $16.34
5/15/20201,340,000 shares $26.40 million -11.3%N/A9.8 $19.70
4/30/20201,510,000 shares $25.82 million -5.0%N/A12.6 $17.10
4/15/20201,590,000 shares $24.61 million +0.6%10.9%14.3 $15.48
3/31/20201,580,000 shares $28.01 million +2.2%11.1%21.7 $17.73
3/13/20201,545,700 shares $21.33 million -0.3%11.0%38.6 $13.80
2/28/20201,550,000 shares $20.94 million -3.7%11.1%24.3 $13.51
2/14/20201,610,000 shares $27.45 million -10.1%11.5%24.8 $17.05
1/31/20201,790,000 shares $38.99 million -2.7%12.8%27.4 $21.78
1/15/20201,840,000 shares $40.96 million No Change13.2%30.4 $22.26
12/31/20191,840,000 shares $41.53 million -9.8%13.2%32.5 $22.57
8/15/20192,019,500 shares $34.47 million -8.6%14.9%29.3 $17.07

CRNX Short Interest - Frequently Asked Questions

What is Crinetics Pharmaceuticals' current short interest?

Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 4,910,000 shares of CRNX short. Learn More on Crinetics Pharmaceuticals' current short interest.

What is a good short interest ratio for Crinetics Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 6.0. Learn More on Crinetics Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Crinetics Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Crinetics Pharmaceuticals: Walleye Trading LLC, Ikarian Capital LLC, StemPoint Capital LP, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

How does Crinetics Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Crinetics Pharmaceuticals: Avadel Pharmaceuticals plc (5.91%), Bicycle Therapeutics plc (6.76%), BeiGene, Ltd. (1.75%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Sarepta Therapeutics, Inc. (6.94%), Catalent, Inc. (3.76%), Roivant Sciences Ltd. (7.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Crinetics Pharmaceuticals stock?

Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading down $0.61 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Crinetics Pharmaceuticals?

A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further.

How often is Crinetics Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:CRNX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners
A once-in-a-century investment opportunity
Stansberry Research
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
4 Cryptos BETTER than Bitcoin
True Market Insiders
Write this ticker symbol down…
StocksToTrade
You won't believe what Citigroup just did to it's depositors
American Alternative
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Bill Clinton Backing Biden Replacement???
The Freeport Society